BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16524741)

  • 41. Chromium picolinate inhibits resistin secretion in insulin-resistant 3T3-L1 adipocytes via activation of amp-activated protein kinase.
    Wang YQ; Dong Y; Yao MH
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):843-9. PubMed ID: 19298540
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxynitrite activates glucose uptake in 3T3-L1 adipocytes through a PI3-K-dependent mechanism.
    Guzman-Grenfell AM; Garcia-Macedo R; Gonzalez-Martinez MT; Hicks JJ; Medina-Navarro R
    Front Biosci; 2005 Jan; 10():47-53. PubMed ID: 15574346
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Rossi A; Eid M; Dodgson J; Davies G; Musial B; Wabitsch M; Church C; Hornigold DC
    Adipocyte; 2020 Dec; 9(1):415-426. PubMed ID: 32718202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-Cysteine supplementation increases adiponectin synthesis and secretion, and GLUT4 and glucose utilization by upregulating disulfide bond A-like protein expression mediated by MCP-1 inhibition in 3T3-L1 adipocytes exposed to high glucose.
    Achari AE; Jain SK
    Mol Cell Biochem; 2016 Mar; 414(1-2):105-13. PubMed ID: 26897632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MDM2-related responses in 3T3-L1 adipocytes exposed to cooling and subsequent rewarming.
    Ohsaka Y; Nishino H
    Cryobiology; 2010 Dec; 61(3):308-16. PubMed ID: 21034728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes.
    Yuan G; Chen X; Ma Q; Qiao J; Li R; Li X; Li S; Tang J; Zhou L; Song H; Chen M
    J Endocrinol; 2007 Aug; 194(2):275-81. PubMed ID: 17641277
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of vanadate on glycogen synthesis in dexamethasone-treated 3T3 adipocytes: evidence for a novel insulin sensitizing action.
    Marita AR; Anilkumar KL
    Diabetes Obes Metab; 2001 Aug; 3(4):271-8. PubMed ID: 11520307
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lipoic acid inhibits adiponectin production in 3T3-L1 adipocytes.
    Prieto-Hontoria PL; Fernández-Galilea M; Pérez-Matute P; Martínez JA; Moreno-Aliaga MJ
    J Physiol Biochem; 2013 Sep; 69(3):595-600. PubMed ID: 23307774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of the cellular content of metabolites in adipocytes by insulin.
    Qiao Y; Tomonaga S; Matsui T; Funaba M
    Mol Cell Endocrinol; 2016 Mar; 424():71-80. PubMed ID: 26811873
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of metabolic risk factors on production of plasminogen activator inhibitor-1 and adiponectin by adipocytes.
    Sakamoto K; Sakamoto T; Ogawa H
    Circ J; 2008 May; 72(5):844-6. PubMed ID: 18441469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of simvastatin on adipose tissue: pleiotropic effects in vivo.
    Khan T; Hamilton MP; Mundy DI; Chua SC; Scherer PE
    Endocrinology; 2009 Dec; 150(12):5262-72. PubMed ID: 19819942
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Structural Basis of Action of Vanadyl (VO
    Makinen MW; Salehitazangi M
    Coord Chem Rev; 2014 Nov; 279():1-22. PubMed ID: 25237207
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biotransformations of Antidiabetic Vanadium Prodrugs in Mammalian Cells and Cell Culture Media: A XANES Spectroscopic Study.
    Levina A; McLeod AI; Pulte A; Aitken JB; Lay PA
    Inorg Chem; 2015 Jul; 54(14):6707-18. PubMed ID: 25906315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tyrosine phosphorylation and morphological transformation induced by four vanadium compounds on MC3T3E1 cells.
    Sálice VC; Cortizo AM; Gómez Dumm CL; Etcheverry SB
    Mol Cell Biochem; 1999 Aug; 198(1-2):119-28. PubMed ID: 10497886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible mechanism of action of vanadium ions as an antidiabetic agent.
    Terziyski K; Tzenova R; Milieva E; Vladeva S
    Folia Med (Plovdiv); 1999; 41(1):34-7. PubMed ID: 10462917
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Organic vanadium chelators potentiate vanadium-evoked glucose metabolism in vitro and in vivo: establishing criteria for optimal chelators.
    Goldwaser I; Qian S; Gershonov E; Fridkin M; Shechter Y
    Mol Pharmacol; 2000 Oct; 58(4):738-46. PubMed ID: 10999943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vanadium compounds as insulin mimics.
    Thompson KH; McNeill JH; Orvig C
    Chem Rev; 1999 Sep; 99(9):2561-72. PubMed ID: 11749492
    [No Abstract]   [Full Text] [Related]  

  • 58. Inverse Association of Plasma Vanadium Concentrations with Gestational Diabetes Mellitus.
    Li X; Zhu Y; Yin J; Li B; Li P; Cao B; Wang Q; Xu J; Liu L
    Nutrients; 2022 Mar; 14(7):. PubMed ID: 35406027
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of a 6-month physical training program on serum and urinary concentrations of trace metals in middle distance elite runners.
    Maynar M; Bartolomé I; Alves J; Barrientos G; Grijota FJ; Robles MC; Muñoz D
    J Int Soc Sports Nutr; 2019 Nov; 16(1):53. PubMed ID: 31727101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vanadium in Biosphere and Its Role in Biological Processes.
    Tripathi D; Mani V; Pal RP
    Biol Trace Elem Res; 2018 Nov; 186(1):52-67. PubMed ID: 29524196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.